Drug makers’ downsizing plan hits snag

The domestic drug industry has hit a snag with its plan to push employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook, with most pharmaceutical firms reluctant to reduce their workforces on concerns over union’s strong resistance and disclosure of illegal rebates by ousted employers.

The government’s plan to cut drug prices by an average of 14 ...